NK cell regulation of CD4 T cell responses
NK cell regulation of CD4 T cell responses
批准号:
9226027
负责人:
Raymond M Welsh
金额:
$47.69万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-03-01 至 2019-02-28
关键词:
Activated Natural Killer CellAcuteAffectAntibody ResponseAntigensArenaviridaeArenavirusB-Lymphocyte SubsetsB-LymphocytesCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCell CountCell physiologyCellsChargeCollaborationsCytolysisCytotoxic T-LymphocytesDevelopmentDiseaseHIVHumanHumoral ImmunitiesImmuneImmune responseImmune systemInfectionInnate Immune SystemInterferonsKnockout MiceLaboratoriesLungLymphocytic choriomeningitis virusMediatingMusNatural Killer CellsPathogenesisPathologyPhasePhysiologicalPoxviridaeProcessRegulationResearch PersonnelRoleSystemT cell responseT-LymphocyteTestingTranslatingVariantViralViral AntibodiesViral PathogenesisViral VaccinesVirusVirus DiseasesWorkantiviral immunitycell killingcytotoxicityexhaustionin vivoinfluenzavirusinsightkillingsmucosal siteprogramsreceptorresponse
中文摘要
对感染的免疫反应发生在两个阶段,早期相对非特异性(先天)反应和后来的特异性(适应性或获得性)反应与T和B细胞抗原反应性克隆的扩张有关。我的实验室在20世纪70年代帮助发展了这一范式,展示了干扰素(干扰素)诱导的激活自然杀伤(NK)细胞峰,随后是病毒特异性细胞毒T细胞峰。NK细胞现在被认为是天然免疫系统中重要的抗病毒成分。矛盾的是,我们现在有令人惊讶的证据表明,NK细胞的枯竭有时可以增强病毒清除或抑制免疫病理疾病。在这种情况下,NK细胞对宿主是有害的,因为它们改变了获得性免疫反应,部分是通过杀死激活的CD4T细胞,后者通过对CDS T细胞和B细胞的作用直接或间接地调节病毒感染。然而,在其他情况下,NK细胞的存在是促进持续感染所必需的,部分原因是它们调节T细胞反应的能力。我们在这里表明,尽管抑制分子2B4抑制NK细胞攻击CDS T细胞,但激活的NK细胞可以杀死激活的CD4T细胞,从而在病毒感染期间减少CD4和CDS T细胞的数量和功能。我们建议使用几种不同的系统来确定NK细胞影响新发育的T细胞反应并有助于肺部病毒疾病发病的机制(S),我们将与其他项目研究人员合作,将这些发现转化为人类系统。具体地说,我们提出了以下具体目标:具体目标1:确定NK细胞对T细胞反应的直接控制是否是抗病毒T细胞反应的普遍特征。具体目标2:与Project 2和Core 0合作,确定易受NK细胞介导的溶解的004 T细胞的功能、生理和抗原状态。具体目的#3:确定NK细胞在调节抗病毒抗体反应中的作用。具体目的#4:研究NK细胞对病理和持久性的依赖调节,以及NK细胞对T细胞耗竭的影响。这项工作符合RFA-AI-12-048的目标,因为它(1)检查病毒系统中固有免疫机制和获得性免疫机制之间的相互作用,(2)检查粘膜部位的这种作用,在这种情况下是肺,以及(3)检查感染后不同的T和B细胞亚群是如何维持的。
英文摘要
Immune responses to infections occur in two phases, an early relatively nonspecitic (innate) response and a later specific (adaptive or acquired).response associated with the expansions of antigen-reactive clones of T and B cells. My laboratory in the 1970s helped develop this paradigm by demonstrating an interferon (IFN)- induced activated natural killer (NK) cell peak followed by a virus-specific cytotoxic T cell peak. NK cells are now considered important anti-viral components of the innate immune system. Paradoxically, we now have surprising evidence that the depletion of NK cells can sometimes enhance viral clearance or inhibit immunopathological disease. Under these conditions NK cells are harmful to host because they alter the acquired immune response, in part by killing activated CD4 T cells, which regulate viral infections directly and indirectly by their actions on CDS T cells and B cells. However, under other conditions the presence of NK cells is needed to promote persistent infections, also in part due to their ability to regulate T cell responses. We show here that whereas the inhibitory molecule 2B4 restrains NK cells from attacking CDS T cells, activated NK cells can kill activated CD4 T cells and in so doing decrease both CD4 and CDS T cell numbers and functionality during viral infections. We propose to determine, using several different systems, the mechanism(s) by which NK cells affect newly developing T cell responses and contribute to the pathogenesis of viral disease in the lung, and we will collaborate with, other program investigators to translate these findings into human systems. Specifically, we propose the following specific aims: Specific Aim #1: To determine whether the direct NK cell control of T cell responses is a universal feature in anti-viral T cell responses. Specific Aim #2: To determine, in collaboration with Project 2 and Core 0, the functional, physiological, and antigenic state of 004 T cells that are susceptible to NK cell mediated lysis. Specific Aim #3: To determine the role of NK cells in regulating antiviral antibody responses. Specific Aim #4: To examine the NK cell-dependent regulation of pathology and persistence and effects of NK cells on T cell exhaustion. The work meets the objectives of RFA-AI-12-048, in that it (1) examines interactions between innate and adaptive immune mechanisms in viral systems, (2) examines such actions at mucosal sites, in this case the lung, and (3) examines how different T and B cell subsets are maintained after infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CD4 T cells in anti-viral immunity and immune pathology
-
批准号:8652531
-
项目类别:
-
资助金额:$236.85万
-
财政年份:2014
-
负责人:Raymond M Welsh
-
依托单位:
CD4 T cells in anti-viral immunity and immune pathology
-
批准号:9443502
-
项目类别:
-
资助金额:$237.52万
-
财政年份:2014
-
负责人:Raymond M Welsh
-
依托单位:
Administrative and quantitative core
-
批准号:9226034
-
项目类别:
-
资助金额:$7.88万
-
财政年份:2014
-
负责人:Raymond M Welsh
-
依托单位:
Effect of Virus Infections on the Maintenance of Transplantation Tolerance
-
批准号:8279392
-
项目类别:
-
资助金额:$30.07万
-
财政年份:2011
-
负责人:Raymond M Welsh
-
依托单位:
Effect of Virus Infections on the Maintenance of Transplantation Tolerance
-
批准号:7994917
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2010
-
负责人:Raymond M Welsh
-
依托单位:
Recombinant Vaccinia Virus with Reduced Virulence
-
批准号:7698922
-
项目类别:
-
资助金额:$64.1万
-
财政年份:2008
-
负责人:Raymond M Welsh
-
依托单位:
B cell activation during viral infection
-
批准号:7483020
-
项目类别:
-
资助金额:$39.85万
-
财政年份:2007
-
负责人:Raymond M Welsh
-
依托单位:
B cell activation during viral infection
-
批准号:7898902
-
项目类别:
-
资助金额:$39.45万
-
财政年份:2007
-
负责人:Raymond M Welsh
-
依托单位:
B cell activation during viral infection
-
批准号:7665442
-
项目类别:
-
资助金额:$39.85万
-
财政年份:2007
-
负责人:Raymond M Welsh
-
依托单位:
B cell activation during viral infection
-
批准号:7246733
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2007
-
负责人:Raymond M Welsh
-
依托单位:
B cell activation during viral infection
-
批准号:8116991
-
项目类别:
-
资助金额:$39.06万
-
财政年份:2007
-
负责人:Raymond M Welsh
-
依托单位:
Virus Induced Immunopathology
-
批准号:7001307
-
项目类别:
-
资助金额:$36.04万
-
财政年份:2004
-
负责人:Raymond M Welsh
-
依托单位:
Virus Induced Immunopathology
-
批准号:6724574
-
项目类别:
-
资助金额:$36.68万
-
财政年份:2004
-
负责人:Raymond M Welsh
-
依托单位:
Virus Induced Immunopathology
-
批准号:6886801
-
项目类别:
-
资助金额:$36.86万
-
财政年份:2004
-
负责人:Raymond M Welsh
-
依托单位:
Virus Induced Immunopathology
-
批准号:7193405
-
项目类别:
-
资助金额:$35.05万
-
财政年份:2004
-
负责人:Raymond M Welsh
-
依托单位:
Virus Induced Immunopathology
-
批准号:7387404
-
项目类别:
-
资助金额:$34.35万
-
财政年份:2004
-
负责人:Raymond M Welsh
-
依托单位:
TOLERANCE AND HOST IMMUNITY TO VIRUS INFECTION
-
批准号:6336290
-
项目类别:
-
资助金额:$23.28万
-
财政年份:2000
-
负责人:Raymond M Welsh
-
依托单位:
TOLERANCE AND HOST IMMUNITY TO VIRUS INFECTION
-
批准号:6229261
-
项目类别:
-
资助金额:$23.28万
-
财政年份:1999
-
负责人:Raymond M Welsh
-
依托单位:
VIRUS INDUCED IMMUNOPATHOLOGY
-
批准号:2079055
-
项目类别:
-
资助金额:$29.37万
-
财政年份:1989
-
负责人:Raymond M Welsh
-
依托单位:
VIRUS-INDUCED IMMUNOPATHOLOGY
-
批准号:3157228
-
项目类别:
-
资助金额:$14.0万
-
财政年份:1989
-
负责人:Raymond M Welsh
-
依托单位:
海外基金